Kim Walpole

About

Trials.ai is leveraging artificial intelligence to provide companies with smarter tools to manage their clinical trials.   Here's what we're doing and why:    When it comes to managing clinical trials today's researchers are racing against tighter deadlines while trying to manage their unique trial needs. Did you know that with all of the advances in medicine over the past 20 years, FIFTY percent of research is still being run using binders with forms and a pen? The other fifty percent end up either using multiple systems or paying for customization that costs excessive time and money. Delays in meeting schedule deadlines can end up costing drug, device and therapeutic companies on the order of MILLIONS per DAY.    Now the FDA is forcing change industry wide by mandating that by Sept 2017, standardized study data be submitted electronically. With 50% of research still being done on paper, this creates a major shift in how these companies collect and handle data that must be synthesized and submitted electronically for FDA approval.    Trials.ai is building an intelligent technology platform that makes it simple to run and manage trials:  We leverage AI to create intelligent workflow automation, provide predictive analytics and recommendations based on study health and end points. Our goal is to provide Sponsors, Sites & CRO's with the smart tools they need to make the clinical trials management process faster, cheaper and easier.